Article, News
Prescient Therapeutics unveils high performance cell therapy technology CellPryme-M
Clinical-stage oncology company Prescient Therapeutics (ASX: PTX) has today unveiled the latest technology in its portfolio, a high-performance platform known as CellPryme-M which is designed to enhance…
Article, News 0
June 8, 2022 AUTHOR – enouvoteam
Article, News
Prescient Therapeutics (ASX:PTX) unveils new cell therapy platform
Prescient Therapeutics (PTX) has unveiled its new cell therapy manufacturing enhancement technology, CellPryme-M. CellPryme-M is a platform technology that produces superior cells during the cell…
June 8, 2022 AUTHOR – enouvoteam
RECENT POSTS
Categories
- Article (102)
- Media (6)
- News (295)
- Uncategorized (1)
- Webcast Video (7)
Tags
AusBiz Biotech Dispatch BioWorld CGT Live Global Victoria Investing Kalkine Kalkine Media Market Herald Market Open Mirage News National Tribune Pitt Street Research Port Jackson Securities Prescient Therapeutics Proactive Investors Reach Markets ShareCafe Share Cafe Small Caps Smallcaps Stockhead Switzer TechKnow Invest Roadshow The Australian The Australian Business Review The Market Herald The Sentiment Yahoo Finance